Padcev (Enfortumab Vedotin) 30mg Injection

Description

Padcev (Enfortumab Vedotin) 30mg is a prescription oncology medicine containing enfortumab vedotin, an antibody-drug conjugate designed to target Nectin-4, a protein expressed on many urothelial cancer cells. It is supplied as a powder for concentrate for solution for infusion and is intended for intravenous administration by qualified healthcare professionals after appropriate preparation. Padcev is used for certain eligible patients with urothelial carcinoma, including bladder cancer, according to the approved indications and local prescribing guidelines.

Uses of Padcev

Padcev (Enfortumab Vedotin) is used for certain eligible adults with urothelial carcinoma, a cancer that commonly affects the bladder and urinary tract. Its approved use depends on the patient’s condition, previous treatments, and the applicable prescribing guidelines in the country of treatment.

Benefits of Padcev in Treatment

• Targets Nectin-4, a protein found on many urothelial cancer cells.
• Delivers a cell-killing agent to targeted cancer cells.
• Provides a treatment option for eligible patients under approved indications.
• May be used alone or in combination with other medicines, depending on the indication and treatment regimen.
• Helps oncologists develop an individualized treatment plan based on the patient’s clinical condition.

Treatment decisions and expected benefits should always be discussed with the treating oncologist.

Side Effects of Padcev

Possible side effects include:

• Skin rash and other skin reactions
• Peripheral neuropathy, including tingling, numbness, or weakness
• Fatigue
• Decreased appetite
• Diarrhea, nausea, or vomiting
• Increased blood glucose levels
• Changes in liver function tests
• Lung inflammation or breathing difficulties

Seek urgent medical attention for blistering or peeling skin, sores affecting the mouth or eyes, new or worsening breathing difficulties, severe weakness, or symptoms of high blood sugar. This list is not exhaustive; refer to the official prescribing information for complete safety details.

Quick Tips

• Use Padcev only under the supervision of a qualified oncologist.
• The medicine must be prepared and administered by trained healthcare professionals as an intravenous infusion.
• Do not self-administer or attempt to prepare the medicine at home.
• Follow the prescribed treatment schedule and attend recommended laboratory tests and follow-up appointments.
• Inform the healthcare team about existing medical conditions and all medicines being taken.
• Report skin changes, numbness, tingling, unusual thirst, frequent urination, or breathing problems promptly.
• Maintain the required refrigerated storage conditions and follow the product’s handling instructions.

To Order : oder@srkpharma.com | Contact SRK Pharma for product availability, pack-size confirmation, quotations, and eligible international supply enquiries, subject to applicable regulations.

Patient Assistance Program (PAP) :  We also support Patient Assistance Programs (PAPs) and Patient Named Programs, helping eligible patients access required medicines through a patient-focused and streamlined process. We support patients and healthcare partners with product sourcing, documentation, order coordination, and delivery assistance, subject to applicable program requirements and country regulations.  We support medicine supply through PAP and Patient Named Programs across countries including the USA, UK, Canada, Australia, India, Brazil, Nigeria, South Africa, UAE, Saudi Arabia, Germany, France, Italy, Spain, Singapore, Malaysia, and other international markets, subject to local authorisations and applicable requirements. Our goal is to make access to essential medicines simpler, reliable, and patient-focused, while supporting patients and healthcare partners throughout the supply process.

Note: PAP participation, product eligibility, and supply arrangements are subject to program approval, product availability, and applicable local laws and regulations.